Magellan Health (MGLN) Cash Flow Statement

Click line-items for a historical chart and %

Net income	40.01M
Depreciation and amortization	77.47M
Non-cash interest expense	385K
Non-cash stock compensation expense	27.57M
Non-cash income tax expense
Restricted cash	78.96M
Accounts receivable, net	-31.93M
Other assets	-72.37M
Accounts payable and accrued liabilities	23.34M
Medical claims payable and other medical liabilities	-18.02M
Other	-57K
Net cash provided by (used in) operating activities
Capital expenditures	-44.35M
Acquisitions and investments in businesses, net of cash acquired	-127.5M
Purchase of investments	-365.52M
Maturity of investments	373.69M
Net cash used in investing activities
Payments on long-term debt and capital lease obligations	-13.57M
Payments to acquire treasury stock	-106.81M
Proceeds from issuance of equity
Proceeds from exercise of stock options and warrants	10.93M
Other	1.27M
Net cash used in financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period	115.43M
Cash and cash equivalents at end of period	164.43M

Entities mentioned with MGLN

View All Entities